SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-20-035234
Filing Date
2020-12-28
Accepted
2020-12-28 18:01:37
Documents
2
Period of Report
2020-12-22

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1597
2 EX-24 DOCUMENT attachment1.htm EX-24 4508
  Complete submission text file 0000899243-20-035234.txt   7707
Mailing Address 80 GUEST STREET 5TH FLOOR BOSTON MA 02135
Business Address 80 GUEST STREET 5TH FLOOR BOSTON MA 02135 617-225-0096
YUMANITY THERAPEUTICS, INC. (Issuer) CIK: 0001445283 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O YUMANITY THERAPEUTICS, INC. 40 GUESS STREET SUITE 4410 BOSTON MA 02135
Business Address
Mohsen Paulash (Reporting) CIK: 0001834063 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37695 | Film No.: 201419449